Outcome of Neonatal Hyperbilirubinemia from a Tertiary Care Hospital in Eastern Nepal: A Cross-sectional Study

Authors

  • Shyam Prasad Kafle B. P. Koirala Institute of Health Sciences, Dharan, Nepal https://orcid.org/0000-0001-6332-9880
  • Mukesh Bhatta B. P. Koirala Institute of Health Sciences, Dharan, Nepal
  • Ramesh Shrestha B. P. Koirala Institute of Health Sciences, Dharan, Nepal
  • Sarita Sitaula B. P. Koirala Institute of Health Sciences, Dharan, Nepal
  • Namu Koirala Purbanchal University School of Health Sciences, Gothgaon, Nepal
  • Anupam Koirala Letang Primary Health Care Center, Letang, Nepal

DOI:

https://doi.org/10.3126/jbpkihs.v4i1.36324

Keywords:

Bilirubin, Nepal, Newborn, Hyperbilirubinemia

Abstract

Background: Timely detection and treatment of pathological hyperbilirubinemia in newborns can prevent acute bilirubin encephalopathy and its consequences. We aimed to identify its occurrence, presentation time, phototherapy duration, need for exchange transfusion, and outcome.

Methods: In this cross-sectional study, we enrolled all the babies admitted for pathological neonatal hyperbilirubinemia in the university hospital of BPKIHS in a one-year duration. Babies with life-threatening congenital malformations or conjugated bilirubin > 20% of total serum bilirubin or > 2 mg/dl were excluded. Obstetric profile of mothers, clinical and laboratory parameters of babies, onset time of pathological jaundice, duration of phototherapy, need for exchange transfusion or intravenous immunoglobulin were recorded. Neonatal outcome was classified as good and poor and its association with potential predictors analyzed. 

Results: One-hundred and fifty babies developed neonatal jaundice requiring treatment. The most common causes included ABO and Rh setting. No cause was found in 26 (18%) babies. One-hundred and eight babies (72%) were only managed with phototherapy whereas 42 (28%) required both phototherapy and double volume exchange therapy. The majority (84.5%) had good outcome without any residual neurological deficit at discharge. Babies with total serum bilirubin > 20 mg/dl at presentation, duration of phototherapy > 44.8 h, ABO setting, hemolysis, and out born status significantly developed  poor outcome (p < 0.05).

Conclusion: About 15% of the babies with hyperbilirubinemia had acute bilirubin encephalopathy at discharge suggestive of poor outcome. Babies with high bilirubin at presentation, longer duration of phototherapy, ABO settings, hemolysis, and out born status developed poor outcome.

Downloads

Download data is not yet available.
Abstract
72
PDF
54

Author Biographies

Shyam Prasad Kafle, B. P. Koirala Institute of Health Sciences, Dharan, Nepal

Department of Pediatrics and Adolescent Medicine

Mukesh Bhatta, B. P. Koirala Institute of Health Sciences, Dharan, Nepal

Department of Pediatrics and adolescent Medicine

Ramesh Shrestha, B. P. Koirala Institute of Health Sciences, Dharan, Nepal

Department of Obstetrics and Gynecology

Sarita Sitaula, B. P. Koirala Institute of Health Sciences, Dharan, Nepal

Department of Obstetrics and Gynecology

Namu Koirala, Purbanchal University School of Health Sciences, Gothgaon, Nepal

Department of Nursing

Downloads

Published

2021-06-30

How to Cite

Kafle, S. P., Bhatta, M., Shrestha, R., Sitaula, S., Koirala, N., & Koirala, A. (2021). Outcome of Neonatal Hyperbilirubinemia from a Tertiary Care Hospital in Eastern Nepal: A Cross-sectional Study. Journal of BP Koirala Institute of Health Sciences, 4(1), 37–42. https://doi.org/10.3126/jbpkihs.v4i1.36324

Issue

Section

Original Articles